Clinical Trials Browser

Phase 2 × Glioblastoma × lonafarnib × Clear all

NCT00038493 2018-10-29

Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme

Phase 2 Completed

Brain Neoplasms, Glioblastoma, Glioma